Olgu Sunumu
Yıl 2018,
Cilt: 10 Sayı: 3, 39 - 41, 26.05.2018
Öz
Abstract
Renal Cell Carsinoma is a tumor which arise from renal tubules epithelium and themost common subtype is clear cell carsinoma. In this case report, a patient diagnosedwith renal cell carcinoma who was admitted to Ordu University Training and Research Hospital Family Medicine Polyclinic with complaint blood sugar regulation, back painand weight loss was discussed. With this case, it was tried to take attention to the importance of approaching with holistically who admitted the family medicine clinic.
Anahtar Kelimeler
Kaynakça
- Kaynaklar 1.Güçer H, Renal Hücreli Karsinomlarda COX-2 Ekspresyonuve Mikrodamar Yoğunluğunun Klinikopatolojik Parametre-lerle Karşılaştırılması. Uzmanlık Tezi 2006 2.Yörükoğlu K, Böbrek Hücreli Kanserlerde Sınıflama, Sitoge-netik ve Patolojik Prognostik Faktörler. Dokuz Eylül Üniver-sitesi Tıp Fakültesi Patoloji Anabilim Dalı 3.Özen A, Dündar Kasapoğlu E, Açıkalın MF,Can C. BerrakHücreli Renal Hücreli Karsinomda Fuhrman Derecesinin Tek-rarlanabilirliğinin ve Prognostik Kullanımının Değerlendiril-mesi. Osmangazi Tıp Dergisi 36(3), 13-20. 4. Novick AC, Campbell SC. Renal Tumors. In: Walsh PC, Re-tik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology.Philadelphia: WB Saunders 2002; 2672-731. 5.Çelik O, Yüksel MB, İpekçi T, Aydoğdu Ö. Renal Hücreli Kan-serde Güncel Tanı ve Tedavi Yöntemleri. The Cystoscop on-line dergi e-ISSN:2148-1347, 166-177 6. Catalona C, Fraioli F, Laghi A. High resolution multidetec-tor CT in the preoperative evaluation of patientswith renal cellcarcinoma. Am J Roentgenol 2003; 180(5): 1271-7. 7. Sheth S, Scatarige JC, Horton KM, Fishman EK. Current con-cepts in the diagnosis and manegement ofrenal cell carcino-ma: role of multidetector CT and three-dimensional CT. Ra-diographics 2001; 21: 237-54. 8. Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T.Immunotherapy for advanced renal cellcancer. Cochrane Da-tabase Syst Rev 2005. 9.Eble JN, Sauter G, Epstein JI, Sesterhenn IA: World Health Organization Classification of Tumors. Pathology and Gene-tics of Tumors of the Urinary System and male Genital Or-gans. IARC Press: Lyon, 2004 10. Srigley JR, Hutter RV, Gelb AB, Henson DE, Kenney G, KingBF, Raziuddin S, Pisansky TM: Current prognostic factors--renal cell carcinoma: Workgroup No.4. Union Internationa-le Contre le Cancer (UICC) and the American Joint Commit-tee on Cancer (AJCC). Cancer, 80: 994-996, 1997 11. Kirkali Z, Lekili M: Renal cell carcinoma: New prognostic fac-tors? Curr Opin Urol, 13: 433-438, 2003. 12. Permpongkosol S, Lind RE, Solomon SB, Kavoussi LR. Re-sult of computerized tomography guidedpercutaneous abla-tion of renal masses with nondiagnostic pre-ablation patho-logical findings. J Urol 2006;176(2): 463-7; discussion 467 13. Hegarty N, Gill I, Kaouk JH, Spaliviero M, Desai M, NovickAC, Remer E. Renal cryoablation: 5-yearoutcomes. J Urol2006; 175; 351. 14. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Longterm follow-up of patients with renal cellcarcinoma treatedwith radiofrequency ablation with curative intent. J Urol 2005;174(1): 61-3 15. Varkarakis IM, Ellaf ME, Inaki T, Bhayani SB, Chan DY, SuLM, et al. Percutaneous radiofrequencyablation of renal mas-ses: Results at a 2 year mean follow-up. J Urol 2005;174(2): 456-60;discussion 460. 16.Ljungberg B, Landberg G, Alamdari FI. Factors of importan-ce for prediction of survival in patients withmetastatic renalcell carcinoma, treated with or without nephrectomy. ScandJ Urol Nephrol 2000; 34:246-51.
Yıl 2018,
Cilt: 10 Sayı: 3, 39 - 41, 26.05.2018
Öz
Öz
Renal hücreli karsinom, böbrek tubulus epitelinden kaynaklanan bir tümördür ve ençok görülen alt tipi berrak hücreli karsinomdur. Bu olgu sunumunda Ordu ÜniversitesiEğitim ve Araştırma Hastanesi Aile Hekimliği polikliniğine kan şekeri regülasyonu, sırtağrısı ve kilo kaybı ile başvuran, Renal Hücreli Karsinom tanısı alan hasta tartışılmıştır. Bu vaka ile Aile Hekimliği polikliniğine gelen hastalara bütüncül yaklaşmanın öne-mine dikkat çekilmeye çalışılmıştır.
Anahtar Kelimeler
Kaynakça
- Kaynaklar 1.Güçer H, Renal Hücreli Karsinomlarda COX-2 Ekspresyonuve Mikrodamar Yoğunluğunun Klinikopatolojik Parametre-lerle Karşılaştırılması. Uzmanlık Tezi 2006 2.Yörükoğlu K, Böbrek Hücreli Kanserlerde Sınıflama, Sitoge-netik ve Patolojik Prognostik Faktörler. Dokuz Eylül Üniver-sitesi Tıp Fakültesi Patoloji Anabilim Dalı 3.Özen A, Dündar Kasapoğlu E, Açıkalın MF,Can C. BerrakHücreli Renal Hücreli Karsinomda Fuhrman Derecesinin Tek-rarlanabilirliğinin ve Prognostik Kullanımının Değerlendiril-mesi. Osmangazi Tıp Dergisi 36(3), 13-20. 4. Novick AC, Campbell SC. Renal Tumors. In: Walsh PC, Re-tik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology.Philadelphia: WB Saunders 2002; 2672-731. 5.Çelik O, Yüksel MB, İpekçi T, Aydoğdu Ö. Renal Hücreli Kan-serde Güncel Tanı ve Tedavi Yöntemleri. The Cystoscop on-line dergi e-ISSN:2148-1347, 166-177 6. Catalona C, Fraioli F, Laghi A. High resolution multidetec-tor CT in the preoperative evaluation of patientswith renal cellcarcinoma. Am J Roentgenol 2003; 180(5): 1271-7. 7. Sheth S, Scatarige JC, Horton KM, Fishman EK. Current con-cepts in the diagnosis and manegement ofrenal cell carcino-ma: role of multidetector CT and three-dimensional CT. Ra-diographics 2001; 21: 237-54. 8. Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T.Immunotherapy for advanced renal cellcancer. Cochrane Da-tabase Syst Rev 2005. 9.Eble JN, Sauter G, Epstein JI, Sesterhenn IA: World Health Organization Classification of Tumors. Pathology and Gene-tics of Tumors of the Urinary System and male Genital Or-gans. IARC Press: Lyon, 2004 10. Srigley JR, Hutter RV, Gelb AB, Henson DE, Kenney G, KingBF, Raziuddin S, Pisansky TM: Current prognostic factors--renal cell carcinoma: Workgroup No.4. Union Internationa-le Contre le Cancer (UICC) and the American Joint Commit-tee on Cancer (AJCC). Cancer, 80: 994-996, 1997 11. Kirkali Z, Lekili M: Renal cell carcinoma: New prognostic fac-tors? Curr Opin Urol, 13: 433-438, 2003. 12. Permpongkosol S, Lind RE, Solomon SB, Kavoussi LR. Re-sult of computerized tomography guidedpercutaneous abla-tion of renal masses with nondiagnostic pre-ablation patho-logical findings. J Urol 2006;176(2): 463-7; discussion 467 13. Hegarty N, Gill I, Kaouk JH, Spaliviero M, Desai M, NovickAC, Remer E. Renal cryoablation: 5-yearoutcomes. J Urol2006; 175; 351. 14. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Longterm follow-up of patients with renal cellcarcinoma treatedwith radiofrequency ablation with curative intent. J Urol 2005;174(1): 61-3 15. Varkarakis IM, Ellaf ME, Inaki T, Bhayani SB, Chan DY, SuLM, et al. Percutaneous radiofrequencyablation of renal mas-ses: Results at a 2 year mean follow-up. J Urol 2005;174(2): 456-60;discussion 460. 16.Ljungberg B, Landberg G, Alamdari FI. Factors of importan-ce for prediction of survival in patients withmetastatic renalcell carcinoma, treated with or without nephrectomy. ScandJ Urol Nephrol 2000; 34:246-51.
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | makaleler |
| Yazarlar | |
| Yayımlanma Tarihi | 26 Mayıs 2018 |
| Yayımlandığı Sayı | Yıl 2018 Cilt: 10 Sayı: 3 |
